Brown Brothers Harriman & Co’s ARK Genomic Revolution ETF ARKG Stock Holding History

Brown Brothers Harriman & Co’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-36	Closed	-$1.03K	–	1149
2024 Q1	$1.03K	Buy	36 +34	+1,700%	+$1.02K	﹤0.01%	1113
2023 Q4	$66	Hold	2	–	–	﹤0.01%	1133
2023 Q3	$56	Hold	2	–	–	﹤0.01%	1201
2023 Q2	$68	Hold	2	–	–	﹤0.01%	1204
2023 Q1	$60	Hold	2	–	–	﹤0.01%	1249
2022 Q4	$56	Hold	2	–	–	﹤0.01%	1235
2022 Q3	$0	Hold	2	–	–	﹤0.01%	1501
2022 Q2	$0	Buy	+2	New	+$70	﹤0.01%	1296
2018 Q2	–	Sell	-452	Closed	-$12K	–	812
2018 Q1	$12K	Buy	+452	New	+$12.2K	﹤0.01%	640

Other funds holding ARKG

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Brown Brothers Harriman & Co's ARKG Position: Q2 2024 in Review

Brown Brothers Harriman & Co sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 36 shares — an estimated $1.03K sold.

Brown Brothers Harriman & Co first reported a position in ARKG in Q1 2018 and held it in 9 quarters. The position peaked at $12K in Q1 2018. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

Brown Brothers Harriman & Co reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
Brown Brothers Harriman & Co sold 36 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $1.03K.
Brown Brothers Harriman & Co first reported a position in ARK Genomic Revolution ETF in Q1 2018 and held it in 9 quarters.
Brown Brothers Harriman & Co's ARK Genomic Revolution ETF position peaked at $12K in Q1 2018.
261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2024, filed 9 Aug 2024.